Bosh sahifaIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Yopilish kursi
0,00 $
Oʻrtacha hajm
372,00
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | 2014info | Y/Y qiyosi |
|---|---|---|
Daromad | 28,89 mln | — |
Joriy xarajat | 33,07 mln | — |
Sof foyda | -30,39 mln | — |
Sof foyda marjasi | -105,18 | — |
Har bir ulushga tushum | -0,58 | 30,12% |
EBITDA | -20,30 mln | — |
Amaldagi soliq stavkasi | -0,80% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | 2014info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,00 mln | — |
Jami aktivlari | 65,48 mln | — |
Jami passivlari | 53,69 mln | — |
Umumiy kapital | 11,79 mln | — |
Tarqatilgan aksiyalar | 62,59 mln | — |
Narxi/balansdagi bahosi | 0,00 | — |
Aktivlardan daromad | -19,15% | — |
Kapitaldan daromad | -31,61% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | 2014info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -30,39 mln | — |
Operatsiyalardan naqd pul | -10,91 mln | — |
Sarmoyadan naqd pul | 4,49 mln | — |
Moliyadan naqd pul | 3,50 mln | — |
Naqd pulning sof oʻzgarishi | -1,38 mln | — |
Boʻsh pul | 4,58 mln | — |
Haqida
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Tashkil etilgan
2005
Bosh ofis
Sayt
Xodimlar soni
121
